<?xml version="1.0" encoding="UTF-8"?>
<p>The binding of SARS-CoV-2 may decrease ACE2 concentrations and increase the angiotensin II to angiotensin (1–7) ratio which may exacerbate pulmonary injury and tissue fibrosis.
 <sup>
  <xref rid="bibr26-0004563220928361" ref-type="bibr">26</xref>
 </sup> Angiotensin (1–7) may provide resilience from the development of pulmonary failure in COVID-19 further supporting this finding.
 <sup>
  <xref rid="bibr49-0004563220928361" ref-type="bibr">49</xref>
 </sup>
</p>
